NASDAQ : VBIO

Valion Bio, Inc. — Earnings Estimates

$0.2212 USD

-$0.09 (-28.65%)

Volume
128.76M
Average Volume
503.19K
Market Capitalization
$916.08K
P/E Ratio
-7.37
Dividend Yield
0.00%
Price Target
Year High
$5.60
Year Low
$0.20
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.57

Annual earnings financials

VBIO financial data with annual/quarterly toggle

VBIO GAAP EPS - Annual & Quarterly

VBIO Sales Revenue - Annual & Quarterly

VBIO Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

VBIO Estimated and Actual Revenue by Quarter
VBIO Estimated and Actual EPS by Quarter
VBIO Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-03-31 1 286K 286K 286K 286K 286K 286K
2028-12-31 1 252K 252K 252K 252K 252K 252K
2028-09-30 1 226K 226K 226K 226K 226K 226K
2028-06-30 1 214K 214K 214K 214K 214K 214K
2028-03-31 1 266K 266K 266K 266K 266K 266K
2027-12-31 1 156K 156K 156K 156K 156K 156K
VBIO Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-03-31 1 -9.56B -9.56B -9.56B 12.51M 12.51M 12.51M
2028-12-31 1 -11.48B -11.48B -11.48B 11.03M 11.03M 11.03M
2028-09-30 1 -11.48B -11.48B -11.48B 9.89M 9.89M 9.89M
2028-06-30 1 -13.39B -13.39B -13.39B 9.36M 9.36M 9.36M
2028-03-31 1 -13.39B -13.39B -13.39B 11.64M 11.64M 11.64M
2027-12-31 1 -13.39B -13.39B -13.39B 6.83M 6.83M 6.83M
VBIO Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-03-31 1 1.43M 1.43M 1.43M 1 -85 -85 -85
2028-12-31 1 1.26M 1.26M 1.26M 1 -102 -102 -102
2028-09-30 1 1.13M 1.13M 1.13M 1 -102 -102 -102
2028-06-30 1 1.07M 1.07M 1.07M 1 -119 -119 -119
2028-03-31 1 1.33M 1.33M 1.33M 1 -119 -119 -119
2027-12-31 1 780K 780K 780K 1 -119 -119 -119